Ayşe Deniz GÖKENGİN

Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Anabilim Dalı

Research areas: Health Sciences, Medicine, Internal Medicine Sciences, Infectious Diseases and Clinical Microbiology, Natural Sciences, Life Sciences, Fundamental Medical Sciences, Microbiology and Clinical Microbiology, Virology, Psychiatry

Publications

• Gaps, Inequities, and Implementation Challenges in Tuberculosis Infection Management among People with HIV in Central and Eastern Europe (2026)
• Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026 (2026)
• Community perceptions of chemsex practices in Türkiye: a cross-sectional online survey (2026)
• The Use of Unproven Drugs for COVID-19 Treatment in People Living with HIV in Central and Eastern Europe (2026)
• Causes of death in people living with human immunodeficiency virus in Türkiye: a multicentre retrospective study (2025)
• HIV-related microaggressions and depressive symptoms among people living with HIV: the mediating roles of internalised stigma and coping with shame (2025)
• Control of HIV across the WHO European region: progress and remaining challenges (2025)
• The Outcome of Coronavirus Disease 2019 among People Living with HIV in European Union versus Non-European Union Countries (2025)
• The Three Pioneers in the Discovery of the Human Immunodeficiency Virus (2025)
• HIV ile Yaşayan Kişilerde Hepatit B ve Hepatit C Koinfeksiyonlarının Yönetimi: Rehber Önerilerine Uyuyor muyuz? (2025)
• HIV-related stigma: effects on health outcomes and directions for stigma-focused interventions (2025)
• Outcomes and gaps in HIV care for migrants in Europe (2024)
• Missed Opportunities in HIV Testing in Turkiye: Implications for Late Diagnoses (2024)
• The HIV epidemic in eastern Europe and central Asia in difficult times: a story of resilience and change (2024)
• Impact of the COVID-19 Pandemic on People Newly Diagnosed with HIV and those Already in -care in Türkiye (2024)
• IUSTI Europe position statement on use of DoxyPEP: June 2024 (2024)
• The Impact of the COVID-19 Pandemic on Syphilis: A Retrospective Study among the Ege University HIV Cohort (2024)
• Evaluation of a SARS-CoV-2 antigen test in the rapid diagnosis of COVID-19 suspected patients (2023)
• Birth Control and Pregnancy Management Among Women Living with HIV (2023)
• Care and Management of Aegean University HIV Cohort: Change Over Time (2023)
• Prevalence of Transmitted Drug Resistance among HIV-1 Patients in the Aegean Region: Results from the Western Part of Turkey (2023)
• Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)
• Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosis (2023)
• Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe (2023)
• After the HIV/AIDS Congress 2022 (24-27 November 2022, Antalya): Gains, Challenges and Recommendations for the Future Response to HIV Infection in Türkiye (2023)
• PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023)
• Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment? (2022)
• Leishmania: Artan hasta sayısına dikkat! Salgın olabilir mi? (2022)
• Evaluation of the Performance of QuantiFERON-TB Gold Plus Assay in Human Immunodeficiency Virus Infection (2022)
• The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022)
• HIV ile Yaşayan Bireylerde Tetanos Aşısının Rapeli Daha Erken Yapılmalı Mı? (2022)
• The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022)
• Sexual transmission of infections across Europe: appraising the present, scoping the future (2022)
• Pregnancy and Neonatal Outcomes Among Women Living with HIV: A Multi-center, Descriptive Study in Turkey (2022)
• Awareness of HIV pre-exposure prophylaxis among men who have sex with men using apps for sexual encounters in Turkiye (2022)
• HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems (2022)
• Living with HIV during COVID-19: knowledge and worry about COVID-19, adherence to COVID-19-related precautions, and HIV health outcomes (2022)
• Switch to DTG+3TC in a Highly Treatment-Experienced Person Living with HIV (2022)
• HIV Pre-Exposure Prophylaxis in Central and Eastern Europe-Gains and Challenges in An Ever-Changing World (2022)
• İnsan immun yetmezlik virüsü (HIV) enfeksiyonu ve pnömotoraks (2021)
• Temas Öncesi ve Sonrası profilaksi (2021)
• The deep impact of the COVID-19 pandemic on medical students: an online cross-sectional study evaluating Turkish students’ anxiety (2021)
• Friend or foe? Evaluation of the effect of BCG vaccine and latent tuberculosis infection on patients diagnosed with COVID-19 (2021)
• The deep impact of the COVID-19 pandemic on medical students: An online cross-sectional study evaluating Turkish students’ anxiety (2021)
• Friend or foe? Evaluation of the effect of BCG vaccination and latent tuberculosis infection on patients diagnosed with COVID 19 (2021)
• One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARS- CoV-2 vaccines for holistic management and achieving global control (2021)
• Changes in the Prevalence of Coccidian Protozoain Immunocompromised Patients Over the Last Decade (2021)
• Missed opportunities in HIV diagnosis: preliminary results (2021)
• Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug–drug interactions among HIV‐positive patients receiving treatment for coronavirus disease 2019 (COVID‐19) (2021)
• Additional file 1 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Programmatic mapping and size estimation of female sex workers, transgender sex workers and men who have sex with men in İstanbul and Ankara, Turkey (2021)
• Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection (2021)
• Additional file 3 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Additional file 1 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Additional file 4 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Additional file 3 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Additional file 4 of Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017 (2021)
• Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection (2021)
• 2021 European guideline on HIV testing in genito‐urinary medicine settings (2021)
• Frequency of Sexually Transmitted Pathogens in HIV- Positive Individuals (2021)
• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients - data from Euroguidelines in Central and Eastern Europe Network Group (2021)
• Treatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey (2021)
• HIV care cascade in Albania: analysis of newly diagnosed cases in 2016 (2020)
• PrEP use and HIV awareness among men who have sex with men (MSM) in Turkey: Preliminary results of a Hornet survey https://cattendee.abstractsonline.com/meeting/9289/Presentation/2006 (2020)
• Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group (2020)
• HIV Enfeksiyonunda QuantiFERON-TB Gold Plus Yönteminin Performansının Değerlendirilmesi (2020)
• SARS-CoV-2 epidemiology and control, different scenarios for Turkey (2020)
• Modelling the future of HIV in Turkey: disease implications of improving prevention, diagnosis and treatment (2020)
• Temporal Trends in the Epidemiology of HIV in Turkey (2020)
• Comparison of Two Anti-HIV Confirmatory Assays: Recombinant HIV 1/2 Line Immunoassay and Geenius HIV 1/2 Confirmatory Test (2020)
• HIV ENFEKSİYONUNUN ERKEN TANISINDA KAÇIRILMIŞ FIRSATLARIN DEĞERLENDİRİLMESİ - ÖN SONUÇLAR (2020)
• The effect of Attention Deficit and Hyperactivity Disorder on Antiretroviral Treatment and Appointment Adherence among adults living with HIV (2020)
• HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe? (2020)
• Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next‐generation sequencing in HIV‐positive patients (2020)
• HIV/AIDS Hastalarında Hepatit B Aşısını Çift Doz mu Yapmalı (2019)
• Programmatic mapping and size estimation of key populations in two major cities: Istanbul and Ankara (2019)
• HIV cascade of care in Turkey: data from the HIV-TR cohort (2019)
• HIV prevalence and risk behavior among men who have sex with men in İstanbul Turkey (2019)
• Almost 40 Years into the HIV Epidemic:Are We Turning the Tide? (2019)
• HIV/AIDS hastalarında hepatit B aşısını çift doz mu yapmalı? (2019)
• The HIV treatment cascade in Turkey. HepHIV2019 Bucharest Conference: Challenges of Timely and Integrated Testing and Care (2019)
• Bağışıklığı Baskılanmış Hastalarda Koksidiyen Protozoon Sıklığının 10 Yıl Ara ile Karşılaştırılması. (2019)
• Exposure to dolutegravir in pregnant women living with HIV in Central and Eastern Europe and neighboring countries — data from the ECEE Network Group (2019)
• HIV epidemic in the Balkans and Turkey (2018)
• HIV pozitif hastalarda Human Papilloma virus prevalansı (2018)
• HIV pozitif Hastalarda Human Papillomavirüs Prevalansı (2018)
• HIV pozitif hastalarda human herpes virus 8 seroprevalansının araştırılması (2018)
• Trends in modification and discontinuation of initial antiretroviral treatment in the Turkish HIV-TR cohort, 2011-2017 (2018)
• Dünden bugüne HIV (2018)
• HIV care in Central and Eastern Europe: How close are we to the target? (2018)
• HIV health care providers are ready to introduce pre‐exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe ( ECEE ) Network Group (2018)
• P085-ATTENTION DEFICIT AND HYPERACTIVITY DISORDER IN HIV-INFECTED INDIVIDUALS: IS IT ASSOCIATED WITH NON-ADHERENCE TO TREATMENT? (2018)
• Sıtma: Sekiz Olgunun Değerlendirilmesi (2018)
• Intestinal Protozoa in Hiv-Infected Patients: A Retrospective Analysis (2018)
• Türkiye’de HIV enfeksiyonu: Hedefe ne kadar yakınız? (2018)
• Yeni potent ART alan hastalarımız: Gerçek yaşam verileri (2018)
• Bölgemizde ve ülkemizde HIV enfeksiyonu epidemiyolojisi: Hedefe ne kadar yakınız? (2018)
• Exposure to dolutegravir in pregnant HIV-positive women in Central and Eastern Europe and neighboring countries: data from the ECEE Network Group (2018)
• HIV Olumlu Hastalarda İnsan Papilloma Virüs Prevalansı (2018)

CV